A Study to Evaluate the Safety and Pharmacokinetics of NTM-1633 vs Placebo Administered Intravenously in Healthy Adults

NCT03603665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Botulism

Interventions

BIOLOGICAL: NTM-1633
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)